Key laboratory research found that low molecular weight fucoidan can effectively inhibit pulmonary fibrosis

A few days ago, the international academic journal Carbohydrate Polymers reported that Zhang Quanbin’s research group from the Key Laboratory of Experimental Marine Biology of the Chinese Academy of Sciences reported that low-molecular-weight fucoidan sulfate reduces the body’s inflammatory response and inhibits the transfer of cell epithelial to mesenchymal lobes, thereby inhibiting the occurrence and development of pulmonary fibrosis.

Quanbin Zhang’s research team has been committed to the preparation and functional research of fucoidan sulfate for many years.

LMWF inhibits bleomycin ( BLM )-induced lung fibrosis in mice

Analysis of the molecular mechanism of LMWF inhibiting the process of pulmonary fibrosis

Associate researcher Wu Ning is the first author and corresponding author of the paper, PhD student Li Zhi is the co-first author of the paper, and researcher Zhang Quanbin is the co-corresponding author of the paper

Ning Wu ^#* ,Zhi Li ^# , Jing Wang, Lihua Geng, Yang Yue, Zhenzhen Deng, Qingchi Wang, Quanbin Zhang* .

DOI: https://doi.

Link to the paper: https://